Boston, MA, United States of America

William P Kaplan

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 18.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024-2025

where 'Filed Patents' based on already Granted Patents

2 patents (USPTO):

Title: The Innovations of William P. Kaplan

Introduction

William P. Kaplan is a notable inventor based in Boston, MA, who has made significant contributions to the field of pharmaceuticals. With a focus on developing innovative compounds, he has been instrumental in advancing treatments for diseases such as Parkinson's Disease.

Latest Patents

Kaplan holds two patents that highlight his expertise in medicinal chemistry. His first patent involves 1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors. This invention is directed towards certain substituted compounds that are potent inhibitors of LRRK2 kinase, which may be useful in treating or preventing diseases associated with this kinase, including Parkinson's Disease. The patent also covers pharmaceutical compositions comprising these compounds and their applications in disease prevention and treatment. His second patent focuses on N-heteroaryl indazole derivatives as LRRK2 inhibitors, which similarly aims to provide effective treatments for diseases linked to LRRK2 kinase.

Career Highlights

William P. Kaplan is currently associated with Merck Sharp & Dohme Corporation, a leading global healthcare company. His work at Merck has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to pharmaceutical innovation.

Collaborations

Throughout his career, Kaplan has worked alongside esteemed colleagues such as John J. Acton, III, and Michael J. Ard

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…